How a new psoriasis medication works in everyday patient care

This trial is observing how deucravacitinib works for people with moderate to severe psoriasis in real-world practice in Italy. Researchers want to understand how effective this medication is, how safe it is, and how it improves patients' quality of life when used in everyday medical care rather than in a controlled research setting.

While this medication has been tested in clinical trials, doctors and patients need to know how well it actually works and how safe it is when people use it in their regular lives—not just in a research laboratory. This study fills that gap by collecting real-world experiences.